“…Consistent with previous reports (Blin et al, 1990;Morris et al, 1994;Hausdorff et al, 1998;Ebersbach et al, 1999a;Schaafsma et al, 2003;Giladi et al, 2005;Sofuwa et al, 2005;Baltadjieva et al, 2006), the patients with PD in this study walked with a reduced gait speed and swing time compared with an age-matched control group and with an increased stride-to-stride variability under the usual walking (no-RAS) condition. The effects of RAS on average gait speed, stride length and swing time were also generally similar to those reported earlier (McIntosh et al, 1997;Freedland et al, 2002;Rubenstein et al, 2002;Howe et al, 2003;Lim et al, 2005;Willems et al, 2006). For the patients with PD, RAS increased gait speed, stride length and swing time, both when RAS was set to the usual step rate and when it was 10% higher.…”